ArticleFrontiers in surgery2025
Clinical utility of the PBAC score in quantifying treatment response to hysteroscopy: a retrospective observational study.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the clinical utility of the Pictorial Blood Loss Assessment Chart (PBAC) as a quantitative tool for measuring treatment response in patients undergoing hysteroscopy for abnormal uterine bleeding (AUB), and to examine its correlation with changes in hemoglobin levels, endometrial thickness, and patient satisfaction. Materials and methods: This retrospective study included 327 patients who underwent hysteroscopy for AUB between January 2021 and January 2024 at a tertiary care center. Patients with incomplete records, inadequate follow-up, technically unsuccessful procedures, concurrent major surgeries, or endometrial cancer were excluded. Postoperative menstrual bleeding was assessed using the Pictorial Blood Loss Assessment Chart (PBAC). Data were analyzed using SPSS version 26, and Results: Of the 327 patients included in the study, 91.1% had a baseline PBAC score ≥100, which significantly decreased following hysteroscopy (mean reduction: 393 points; Conclusions: Hysteroscopy demonstrated clinical efficacy in the management of abnormal uterine bleeding. Assessment using the PBAC score provided a feasible and informative method for quantifying treatment response, supporting its role as a valuable tool in the objective evaluation of bleeding outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.